ペプチド-ナノ粒子プラットフォームによるアンチセンス治療:脳送達のための粗視的モデリングアプローチ
Burcu Yesildag Uner1, Alper Demir2, Pingkun Zhou3
1Department of Genetics and Bioengineering, Yeditepe University, Faculty of Engineering, Istanbul, Turkey.
Computers in biology and medicine
|January 25, 2026
まとめ
人工知能は、外傷性脳損傷(TBI)によって破壊された主要な遺伝子回路を特定しました。これにより、TBI治療における精密神経治療のための標的ナノ粒子が開発されました。
科学分野:
- 神経科学
- バイオテクノロジー
- 計算生物学
背景:
- 外傷性脳損傷(TBI)は、重大な長期神経学的障害を引き起こします。
- 神経炎症、酸化ストレス、ミトコンドリアダイナミクスにおける遺伝子回路の破壊は、TBIの神経病理学の鍵となります。
研究 の 目的:
- AI駆動型のマルチオミクス統合を使用してTBIにおけるシグナル伝達経路の変化をマッピングすること。
- 破壊された遺伝子回路内の治療標的を特定すること。
- 精密TBI治療のためのAIガイド型ナノキャリアシステムを設計すること。
主な方法:
- プロテオミクスおよびRNAシーケンシングデータを人工知能を使用して統合しました。
- 計算分析を実行して、治療介入ノードを予測しました。
- 標的送達のためのインシリコ応答性ナノ粒子製剤を設計および最適化しました。
主要な成果:
- 酸化還元感受性ミトコンドリア調節因子および神経免疫インターフェース遺伝子を含む、特定の遺伝子回路ノードを潜在的な治療標的として特定しました。
- 標的リガンドと酸化還元感受性放出を備えたAI予測インシリコ最適化ナノ粒子製剤を開発しました。
- AIネットワークプロファイリングとナノキャリア設計を統合した、クローズドループのデータ駆動型戦略を実証しました。
結論:
- AI駆動型のマルチオミクスデータ分析は、ヒトTBIの神経病理学への翻訳的窓を提供します。
- このアプローチにより、TBIのような複雑な疾患に対する精密神経治療の合理的な設計が可能になります。
- 開発されたプラットフォームは、神経疾患におけるデータ駆動型治療戦略のスケーラブルなフレームワークを提供します。
関連する概念動画
Shape and Texture of Coarse Aggregate
676
Aggregate shape is classified based on the relative sharpness or roundness of the edges and corners. This classification includes categories like rounded, angular, elongated, and flaky, each with specific characteristics. Rounded aggregates, fully shaped by attrition, are typical of river or seashore gravel, while angular aggregates, such as crushed rock, have well-defined edges. Aggregates that are elongated and flaky are less desirable, as they can reduce the workability and strength of...
676
Peptide Bonds
82.6K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.6K
Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Model Approaches for Pharmacokinetic Data: Physiological Models
259
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
259
Model Approaches for Pharmacokinetic Data: Compartment Models
545
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
545
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
247
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
247


